Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel Diseases
- 8 November 2007
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 53 (7), 1910-1916
- https://doi.org/10.1007/s10620-007-0075-z
Abstract
The aims of this study were to investigate the expression of pentraxin-3 in inflamed gastrointestinal tissue in patients with inflammatory bowel diseases and to elucidate the usefulness of plasma pentraxin-3 level as an inflammation marker in patients with inflammatory bowel diseases. Pentraxin-3 immunoreactivity was found in infiltrating neutrophils and vessels in the inflamed gut. Plasma pentraxin-3 concentration in patients with active inflammatory bowel diseases was significantly higher than that of normal subjects and patients with inactive inflammatory bowel diseases. Significant positive correlations of clinical disease activity with plasma pentraxin-3 concentration and serum CRP concentration were found in patients with inflammatory bowel diseases. Pentraxin-3 is directly produced from the inflamed gut in inflammatory bowel diseases. In conclusion, plasma pentraxin-3 concentration is a useful marker for understanding the disease activity in patients with inflammatory bowel diseases.Keywords
This publication has 47 references indexed in Scilit:
- The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular trapsThe Journal of Experimental Medicine, 2007
- Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- The role of C-reactive protein as an inflammatory marker in gastrointestinal diseasesNature Clinical Practice Gastroenterology & Hepatology, 2005
- Human renal epithelial cells produce the long pentraxin PTX3Kidney International, 2005
- Characterization of the long pentraxin PTX3 as a TNFα-induced secreted protein of adipose cellsJournal of Lipid Research, 2003
- Cytokines and Inflammatory Bowel Disease: A ReviewJournal of Parenteral and Enteral Nutrition, 1999
- Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1995
- Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.Gut, 1994
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease.Gut, 1987